Raw Material BusinessOEM BusinessPharmaceutical BusinessOverseas BusinessResearch & DevelopmentPharmaceutical Raw Material ManufacturingCosmetic Raw Material ManufacturingHealth Food ManufacturingPlacenta Raw Material ManufacturingLactic Acid Bacteria Raw Material ManufacturingOEM Manufacturing
§04
Related companies
1 COMPANIES
Company name
Group
Parent
Subsidiary
Customer
Supplier
Alliance
Bank
Shareholder
韓国人蔘公社
Supplier
Names without a link are companies not yet registered in OpenBizGraph
§05
Network
NETWORK
Loading the relationship graph...
Drag to move · click to open
§06
History
60 EVENTS
Established Snowden Corporation by Yoshizo Akabane in Kawaguchi City, Saitama Prefecture
Established: July 21, 1977
Completed Omiya Factory in Omiya City, Saitama Prefecture (now Saitama City), and started prototype production of Placenta Extract Products
September: Completed Omiya Factory in Saitama Prefecture (now Saitama City), started prototype production of Placenta Extract products
Obtained license for general pharmaceutical sales business
June 1978: Obtained general sales permit for pharmaceuticals
Relocated headquarters to Chuo Ward, Tokyo
February 1979: Moved headquarters to Chuo Ward, Tokyo
Obtained manufacturing business license for pharmaceuticals from the Ministry of Health, Labour and Welfare
June: Obtained manufacturing license for pharmaceuticals from the Ministry of Health and Welfare
Relocated headquarters to Chiyoda Ward, Tokyo (current location)
October 1981: Moved headquarters to Chiyoda Ward, Tokyo (current location)
Yoshizo Akabane assumed the position of President and Chairman
January 1983: Yoshizo Akabe became President and Chairman
Obtained import and sales license for pharmaceuticals
March: Obtained import and sales license for pharmaceuticals
Completed GMP-compliant Tokyo Factory in Omiya City, Saitama Prefecture
June 1986: Completed GMP-compliant Tokyo Factory in Omiya, Saitama Prefecture
Launch of pharmaceutical product "Placentop® Sugar Coated Tablets" as a selected chain product from SS Pharmaceutical Co., Ltd.
June 1989: Launched "Placenta Top® Sugar-Coated Tablets" as a chain-selected product from SS Pharmaceutical Co., Ltd.
Launch of pharmaceutical product "Placentop® Liquid" as a selected chain product from SS Pharmaceutical Co., Ltd.
August 1991: Launched "Placenta Top® Liquid" as a chain-selected product from SS Pharmaceutical Co., Ltd.
Launch of two cosmetic products "Senesis" as selected chain products from SS Pharmaceutical Co., Ltd.
January 1993: Launched two cosmetic products "Senesis" from SS Pharmaceutical Co., Ltd. as chain-selected products
Import and launch of pharmaceutical product "Hwasun 28" manufactured by Korean Ginseng Corporation, sold by Meiji Co., Ltd.
March 1994: Imported and launched the pharmaceutical "Hwasun 28" manufactured by Korea Ginseng Corporation
Change from bovine-derived placenta extract to porcine-derived placenta extract cosmetics raw materials due to the impact of mad cow disease.
March 2001: Changed from bovine-derived placenta extract to porcine-derived placenta extract raw materials for cosmetics due to BSE concerns
Launch of three pharmaceutical products "Junggwan Jang Koryo Red Ginseng Tablets s, s,丸s" manufactured by Korean Ginseng Corporation.
February 2003: Launched three pharmaceuticals "Jeonggwanjang Koryo Red Ginseng Tablets s, s, s" manufactured by Korea Ginseng Corporation
Application and approval of pig-derived pharmaceuticals under the Pharmaceutical Affairs Law, replacing human-derived pharmaceuticals.
Launch of "Placentop Liquid®" (changed from SS Pharmaceutical Co., Ltd. selected product to in-house sales).
March: Applied for and approved the change from human-derived pharmaceuticals to porcine-derived pharmaceuticals under pharmaceutical law regulations
March: Launched "Placenta Top Liquid®" (changed from SS Pharmaceutical Co., Ltd. special selection to self-sales)
Launch of "Placentop Tablets®" (changed from SS Pharmaceutical Co., Ltd. selected product to in-house sales).
August: Launched "Placenta Top Tablets®" (changed from SS Pharmaceutical Co., Ltd. special selection to self-sales)
Launch of the "Senesis" series of cosmetics (changed from SS Pharmaceutical Co., Ltd. selected product to in-house sales).
October: Launch of the cosmetics "Senesis" series (changed from special selection products of SS Pharmaceutical Co., Ltd. to in-house sales)
Launch of pharmaceutical product "Junggwan Jang Koryo Emperor Liquid" manufactured by Korean Ginseng Corporation.
June 2005: Launched the pharmaceutical "Jeonggwanjang Koryeo Emperor Liquid" manufactured by Korea Ginseng Corporation
Start of sales of horse-derived placenta extract raw materials.
April 2007: Started selling raw materials derived from horse-derived placenta extract
Completion of new factory (Kumagaya Factory) in Kumagaya City, Saitama Prefecture.
October 2015: Completed a new factory (Kumagaya Factory) in Kumagaya City, Saitama Prefecture
Start of raw material supply for Lactobacillus LJ88.
April 2016: Started supplying raw materials for Lactobacillus LJ88
Launch of product "Gastro Balance" using Lactobacillus LJ88 sterilized powder.
August: Launched products "Gastro Balance" using sterilized Lactobacillus LJ88 powder
Kumagaya Factory obtained GMP certification for health foods from the Japan Health and Nutrition Food Association.
February 2017: Kumagaya Factory obtained GMP compliance certification for health foods from the Japan Health and Nutrition Food Association
Yoshizo Akabane appointed as Chairman and Tadao Nakagawa as President.
July 2019: Yoshizo Akakabe appointed as Chairman and Tadao Nakagawa as President
Yoshizo Akabane resigned as Chairman and became Honorary Director; Masahide Akabane appointed as Chairman; Fumiya Akabane appointed as Vice Chairman.
December 2021: Yoshizo Akakabe retired as Chairman and became Honorary Director; Masahide Akakabe appointed as Chairman; Fumiya Akakabe appointed as Vice Chairman
Start of sales of "Lactic Acid Bacteria Decomposed Placenta Fermentation Liquid" cosmetics raw material.
Yoshizo Akabane resigned as Honorary Director and became Honorary Chairman.
August 2023: Yoshizo Akakabe retired as Honorary Chairman and became Honorary Chairman
Received the transfer of the domestic sales business of "Ginseng" products from Meiji Co., Ltd.: (Previously imported from Korea Ginseng Corporation and sold domestically by Meiji Co., Ltd., now changed to self-sales)
April 2024: Acquired domestic sales business of "Hwasun" products from Meiji Co., Ltd. (changed from importing from Korea Ginseng Corporation and Meiji Co., Ltd. handling domestic sales to in-house sales)
Started sales of cosmetic raw material "Lactic Acid Bacteria Fermented Asparagus Extract Powder"
§07
News
13 ARTICLES
Website Suspension and Emergency Maintenance Due to PHP Vulnerability Response
In response to a critical PHP vulnerability, we temporarily suspended our company website and performed emergency maintenance. The suspension period was from 5:30 p.m. on October 22, 2026 to 5:10 p.m. on October 24, 2026. We apologize for the inconvenience and disruption caused by the sudden service interruption.
Notice of Snowden Corporation Closure
November 2, 2026 (Monday) will be a holiday. Inquiries by phone will also be suspended.
Message of Sympathy Following the 2026 Kumamoto Earthquake
Snowden Co., Ltd. extends its condolences to those who lost their lives in the 2026 Kumamoto earthquake and its sympathies to everyone affected. The company wishes for their safety and recovery.
Summer Holiday Closure
Snowden Co., Ltd. will be closed for its summer holidays from August 8 through August 16, 2026. Services will be temporarily suspended during this period, and regular operations will resume on August 17.
Telephone Support Suspended as Typhoon No. 6 Approaches
Due to the approach of Typhoon No. 6, telephone support from the main switchboard and customer service center will be suspended on Wednesday, June 3, 2026. The company apologizes for any inconvenience and appreciates customers’ understanding.
Interview with Snowden President Masahide Akakabe Published
An interview with Snowden Co., Ltd. president Masahide Akakabe appeared in the “Member Company Close-Up” section of the combined March 21 and 28, 2026 issue of Weekly Diamond.
Year-End and New Year Holiday Closure
Snowden Co., Ltd. will be closed for its winter holidays from December 26, 2025, through January 4, 2026. The company will also be closed all day on January 5, 2026, for an internal event. Telephone inquiries will not be available during the closure.
Snowden’s Placentope Liquid Featured in “CLASSY.”
Snowden Co., Ltd.’s pharmaceutical product Placentope Liquid was featured in the February 2025 issue of “CLASSY.” The article appeared in a section about winter inner-body care.
Message of Sympathy Following the 2024 Noto Peninsula Earthquake
Snowden Co., Ltd. extends its condolences to those who lost their lives in the 2024 Noto Peninsula earthquake and its sympathies to everyone affected. The company wishes for their safety and the region’s recovery.
Snowden’s Lactic Acid Bacterium LJ88 Featured on Television
Snowden’s lactic acid bacterium LJ88 was featured in a segment about stress on “Zubari! Oshiemasho,” a Nippon TV special broadcast on October 21, 2023.
§08
Public records
GOV
National Tax Agency basic information2010001020449
Source: National Tax Agency Corporate Number Publication Site, basic three items
Trade name
スノーデン株式会社
Trade name (kana)
スノーデン
Name in English
Corporation type
301
Address
〒101-0032 東京都千代田区岩本町3丁目7番16号
Postal code
1010032
Prefecture code
13
City code
101
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2018-09-12
Change date
2015-10-05
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
1
Trade name image ID
Address image ID
Sequence number
1419645
METI gBizINFO2010001020449
Source: gBizINFO (Ministry of Economy, Trade and Industry)